Dr Alice M Turner MBChB (Hons), MRCP, PGCE (MedEd), PhD

Dr Alice Turner

Institute of Applied Health Research
Professor of Respiratory Medicine
Honorary Consultant Respiratory Physician

Contact details

Institute of Applied Health Research
University of Birmingham
B15 2TT

Alice’s research interests are predominantly in clinical aspects of alpha 1 antitrypsin deficiency (AATD) and chronic obstructive pulmonary disease (COPD), fields in which she has published widely. Optimising monitoring and therapy for AATD is a major focus for her group. They are also studying aspects of care delivery for COPD, particularly those that span from secondary into primary care and including clinical trials that optimise self-management of COPD.


  • FRCP 2020
  • PGDip Leadership & quality improvement 2019
  • PhD in Respiratory Medicine 2010
  • PGC in Medical Education 2007
  • MRCP 2004
  • MBChB (Hons) 2001


PG Cert in Respiratory Medicine

MBChB (year 5 lead, conference poster module lead (year 4))

BMedSci (dissertation projects)

BClinSci (dissertation projects)

PGC/Dip/Masters Respiratory Medicine (Programme lead)

Postgraduate supervision

Alice Turner’s research interests are predominantly in chronic obstructive pulmonary disease and alpha 1 antitrypsin deficiency, fields in which she has published widely. She lectures to both Medical and Dental Students at the University and is involved in clinical teaching and examining in several local hospitals.

The following is a list of recent or current postgraduate degree supervision. Enquiries from self-funded potential students or those wishing to pursue a Fellowship in Dr Turner's current areas of research interest are welcome by email.

PhD - Cell specific genomics exploring shared pathogenesis between COPD and lung cancer (year 2)
PhD - The role of hypoxia in vascular co-morbidity in chronic inflammatory disease (write up)

Other activities

Academic/clinical committees

•           International

o          ERS AATD task force (2015-)

o          EARCO European AATD registry steering group (2018-)

o          Clinical Biomarker Qualification consortium, imaging subgroup (2018-)

•           National

o          BTS working party for care bundles (2013-14) 

o          BTS Specialist Advisory Group (SAG) on COPD (2015-18)

o          West Midlands Quality Review Service COPD steering group (2016-)

o          NICE health technology appraisal committee (2018-21)

o          NIHR HTA prioritization committee (2019-)

o          BTS quality improvement committee (2019-22)


Recent publications


Faqihi, BM, Trethewey, S, Morlet, J, Parekh, D & Turner, A 2021, 'Bilevel positive airway pressure ventilation for non-COPD acute hypercapnic respiratory failure patients: a systematic review and meta-analysis', Annals of Thoracic Medicine. <http://www.thoracicmedicine.org/>

Channa, S, Gale, N, Lai, E, Hall, L, Quinn, M & Turner, A 2021, 'Colour vision deficiency and sputum colour charts in COPD patients: an exploratory mixed-method study', Primary Care Respiratory Journal, vol. 31, no. 1, 13 . https://doi.org/10.1038/s41533-021-00225-z

Morice, A, Smith, JA, McGarvey, L, Birring, SS, Parker, SM, Turner, A, Hummel, T, Gashaw, I, Fels, L, Klein, S, Francke, K & Friedrich, C 2021, 'Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study', The European respiratory journal, vol. 57, no. 5, 2004240. https://doi.org/10.1183/13993003.04240-2020

Crapo, J, Gupta, A, Lynch, DA, Vogel-Claussen, J, Watz, H, Turner, A, Mroz, RM, Janssens, W, Ludwig-Sengpiel, A, Beck, M, Langellier, B, Ittrich, C, Risse, F & Diefenbach, C 2021, 'FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD', BMJ open, vol. 11, no. 3, e042526. https://doi.org/10.1136/bmjopen-2020-042526

European Alpha-1 Liver Study Group 2021, 'Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency', Gut. https://doi.org/10.1136/gutjnl-2020-323729

Adab, P, Jordan, R, Fitzmaurice, D, Ayres, J, Cheng, KK, Cooper, B, Daley, A, Dickens, A, Enocson, A, Greenfield, S, Haroon, S, Jolly, K, Jowett, S, Lambe, T, Martin, J, Miller, M, Rai, K, Riley, RD, Sadhra, S, Sitch, A, Siebert, S, Stockley, RA & Turner, A 2020, 'Chronic obstructive pulmonary disease in primary care; from case finding to improving patient outcomes: the Birmingham Lung Improvement Studies (BLISS) research programme', NIHR Journals Library. <https://www.journalslibrary.nihr.ac.uk/#/>

Quinn, M & Turner, A 2020, 'Modernising case finding for Alpha-1-antitrypsin deficiency by DNA sequencing of COPD patients', The European respiratory journal.

Quinn, M, Ellis, P, Pye, A & Turner, A 2020, 'Obstacles to early diagnosis and treatment of alpha-1 antitrypsin deficiency: current perspectives', Therapeutics and Clinical Risk Management, vol. 16, pp. 1243—1255. https://doi.org/10.2147/TCRM.S234377

Alonso Pérez, T, García Castillo, E, Ancochea, J, Pastor-Sanz, TM, Almagro, P, Martínez-Camblor, P, Miravitlles, M, Rodriguez-Carballeira, M, Navarro, A, Lamprecht, B, Ramírez-García Luna, AS, Kaiser, B, Alfageme, I, Casanova, C, Esteban, C, Soler-Cataluña, JJ, de-Torres, JP, Celli, BR, Marin, JM, Lopez-Campos, JL, Ter Riet, G, Sobradillo, P, Lange, P, Garcia-Aymerich, J, Antó, JM, Turner, A, Han, MK, Langhammer, A, Sternberg, A, Leivseth, L & Bakke, P 2020, 'Sex differences between women and men with COPD: A new analysis of the 3CIA study', Respiratory Medicine.

Chukowry, PS, Spittle, D & Turner, A 2020, 'Small Airways Disease, Biomarkers and COPD: Where are We?', International journal of chronic obstructive pulmonary disease.

Chukowry, P, Edgar, R & Turner, A 2019, 'Alpha 1 antitrypsin deficiency: a rare multisystem disease, predominantly affecting the lung', Expert Opinion on Orphan Drugs, vol. 7, no. 7-8, pp. 315-326. https://doi.org/10.1080/21678707.2019.1651640

Horvath, I, Canotilho, M, Chlumský, J, Chorostowska-Wynimko, J, Corda, L, Derom, E, Ficker, JH, Kneussl, M, Miravitlles, M, Sucena, M, Thabut, G, Turner, A, van ’t Wout, E & McElvaney, NG 2019, 'Diagnosis and management of Alpha 1 Antitrypsin deficiency in Europe: an expert survey', ERJ Open Research, vol. 5, no. 1. https://doi.org/10.1183/23120541.00171-2018


García Castillo, E, Alonso Pérez, T, Ancochea, J, Pastor-Sanz, TM, Almagro, P, Martinez-Camblor, P, Rodriguez-Carballeira, M, Navarro, A, Lamprecht, B, Sofia Ramírez, A, Kaiser, B, Alfageme, I, Casanova, C, Esteban, C, Soler Cataluña, JJ, Celli, B, Marin, JM, Ter Riet, G, Sobradillo, P, Lange, P, Garcia-Aymerich, J, Antó, JM, Turner, A, Han, M, Langhammer, A, Vikjord, SA, Sternberg, A, Leivseth, L, Bakke, P, Johannessen, A, Oga, T, Cosio, B, IdISBa, CIBERES, Echazarreta, A, Roche, N, Burgel, P-R, Sin, D, Puhan, M, Lopez-Campos, JL, Carrasco, L & Soriano, JB 2020, 'Mortality prediction in chronic obstructive pulmonary disease comparing GOLD2015 and GOLD2019 staging: a pooled analysis of individual patient data', The European respiratory journal, vol. 56, no. Supp 64, 966. https://doi.org/10.1183/13993003.congress-2020.966


Ellis, P & Turner, A 2020, 'Personalising exacerbation prediction strategies in chronic obstructive pulmonary disease', World Journal of Respirology, vol. 10, no. 2, 56444, pp. 11-16. <https://www.f6publishing.com/ArticleInPressDetail?id=56444>

Review article

Rangaraju, M & Turner, A 2020, 'Why is Disease Penetration so Variable in Alpha-1 Antitrypsin Deficiency? The Contribution of Environmental Factors', Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, pp. 280-289. https://doi.org/10.15326/jcopdf.7.3.2019.0177

View all publications in research portal